,Simon More,Vasileios Bampidis,Diane Benford,Claude Bragard,Thorhallur Halldorsson,Antonio Hernández‐Jerez,Susanne Hougaard Bennekou,Kostas Koutsoumanis,Claude Lambré,Kyriaki Machera,Hanspeter Naegeli,Søren Nielsen,Josef Schlatter,Dieter Schrenk,Vittorio Silano (deceased),Dominique Turck,Maged Younes,Jacqueline Castenmiller,Qasim Chaudhry,Francesco Cubadda,Roland Franz,David Gott,Jan Mast,Alicja Mortensen,Agnes G. Oomen,Stefan Weigel,Eric Barthelemy,Ana Rincon,José Tarazona,Reinhilde Schoonjans,

Abstract:The EFSA has updated the Guidance on risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain, human and animal health. It covers the application areas within EFSA's remit, including novel foods, food contact materials, food/feed additives and pesticides. The updated guidance, now Scientific Committee Guidance on nano risk assessment (SC Guidance on Nano-RA), has taken account of relevant scientific studies that provide insights to physico-chemical properties, exposure assessment and hazard characterisation of nanomaterials and areas of applicability. Together with the accompanying Guidance on Technical requirements for regulated food and feed product applications to establish the presence of small particles including nanoparticles (Guidance on Particle-TR), the SC Guidance on Nano-RA specifically elaborates on physico-chemical characterisation, key parameters that should be measured, methods and techniques that can be used for characterisation of nanomaterials and their determination in complex matrices. The SC Guidance on Nano-RA also details aspects relating to exposure assessment and hazard identification and characterisation. In particular, nanospecific considerations relating to in vitro/in vivo toxicological studies are discussed and a tiered framework for toxicological testing is outlined. Furthermore, in vitro degradation, toxicokinetics, genotoxicity, local and systemic toxicity as well as general issues relating to testing of nanomaterials are described. Depending on the initial tier results, additional studies may be needed to investigate reproductive and developmental toxicity, chronic toxicity and carcinogenicity, immunotoxicity and allergenicity, neurotoxicity, effects on gut microbiome and endocrine activity. The possible use of read-across to fill data gaps as well as the potential use of integrated testing strategies and the knowledge of modes or mechanisms of action are also discussed. The Guidance proposes approaches to risk characterisation and uncertainty analysis.

Guidance on the assessment of the safety of feed additives for the users

Guidance on the characterisation of microorganisms used as feed additives or as production organisms

Assessment of the feed additive consisting of Pediococcus pentosaceus DSM 14021 for all animal species for the renewal of its authorisation (Chr. Hansen A/S)

Safety and efficacy of a feed additive consisting of sodium bisulphate for all animal species except aquatic animals (Grillo Werke AG & Jones‐Hamilton Co.)

Re‐evaluation of polyvinylpyrrolidone (E 1201) and polyvinylpolypyrrolidone (E 1202) as food additives and extension of use of polyvinylpyrrolidone (E 1201)

Safety and efficacy of a feed additive consisting of iron (II) chelate of amino acids hydrate for all animal species

Safety and efficacy of a feed additive consisting of fumaric acid for all animal species for the renewal of its authorisation and extension of use (Life SUPPLIES NV)

Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health

Safety and efficacy of a feed additive consisting of Pediococcus acidilactici CNCM I-4622 for all insect species (Danstar Ferment AG)

Risk assessment of feed components of botanical origin – Approaches taken in the European Union

Assessment of the application for renewal of the authorization of a feed additive consisting of urea for ruminants (Borealis L.A.T. GmbH, SKW Stickstoffwerke Piesteritz GmbH and Yara France)

Safety and efficacy of a feed additive consisting of a tincture derived from the roots of Angelica sinensis (Oliv.) Diels (dong quai tincture) for use in poultry, horses, dogs and cats (FEFANA asbl)

Safety and efficacy of a feed additive consisting of Saccharomyces cerevisiae DBVPG 48 SF (BioCell®) for horses, pigs and ruminants (Mazzoleni S.p.A.)

Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow‐on formula manufactured from protein hydrolysates

Safety and efficacy of a feed additive consisting of an essential oil derived from Eucalyptus globulus Labill. (eucalyptus oil) for all animal species (FEFANA asbl)

Safety and efficacy of a feed additive consisting of a tincture derived from the flowers of Syzygium aromaticum (L.) Merr. & L.M. Perry (clove tincture) for all animal species (FEFANA asbl)

Safety and efficacy of a feed additive consisting of an essential oil from the herbaceous parts of Pelargonium graveolens L'Hér. (geranium rose oil) for all animal species (FEFANA asbl)

Safety and efficacy of a feed additive consisting of the seed husk of Plantago ovata Forssk. for use in cats and dogs (C.I.A.M.)

Risk-Benefit Assessment of Feed Additives in the One Health Perspective